Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PharmaEssentia | Taiwan | Healthcare | Biotechnology & Medical Research | NT$166.97B | 41.1x | 0.2 | NT$501 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.2% Upside | Upgrade to Pro+ | |
Lumosa Therapeutics | TPEX | Healthcare | Biotechnology & Medical Research | NT$29.29B | -45.7x | 0.39 | NT$173.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 32.6% Upside | Upgrade to Pro+ | |
Polaris Group | Taiwan | Healthcare | Biotechnology & Medical Research | NT$27.04B | -9.6x | 0.15 | NT$35.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sunmax BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$22.47B | 32.2x | -18.32 | NT$412.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiMed Biologics | TPEX | Healthcare | Biotechnology & Medical Research | NT$21.69B | -90.5x | 0.85 | NT$79.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tanvex BioPharma | Taiwan | Healthcare | Biotechnology & Medical Research | NT$13.33B | -7.9x | -0.21 | NT$55.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gongwin Biopharm | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.57B | -184.2x | -5.35 | NT$102.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Foresee Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$12.06B | -8x | 0.16 | NT$77.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaEngine | TPEX | Healthcare | Biotechnology & Medical Research | NT$9.58B | 5.9x | 0.02 | NT$66.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OBI Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$8.40B | -3.3x | 1.47 | NT$31.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mycenax Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$7.33B | -14.7x | -4.79 | NT$35.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medigen BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$4.20B | -55.2x | -0.67 | NT$30.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bionet | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.86B | 54.4x | 4.03 | NT$76.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SINEW Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.46B | -24.4x | -1.17 | NT$48.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Senhwa Biosciences | TPEX | Healthcare | Biotechnology & Medical Research | NT$3.32B | -11.9x | -2.67 | NT$37.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiRx | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.55B | -18.3x | -0.4 | NT$23.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
GlycoNex | TPEX | Healthcare | Biotechnology & Medical Research | NT$2.55B | -12.6x | -0.71 | NT$23.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Applied BioCode | Taiwan | Healthcare | Biotechnology & Medical Research | NT$2.01B | -8x | 0.66 | NT$19.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.5% Upside | Upgrade to Pro+ | |
Golden BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.82B | -5.7x | -0.22 | NT$11.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Twi BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.67B | -10.8x | -0.31 | NT$19.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Abnova | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.58B | -241.2x | 2.19 | NT$26.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genomics BioSci &Tech | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.53B | -8.6x | 0.71 | NT$21.15 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Genesis Genetics Asia | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.40B | 43.4x | -1.62 | NT$52.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dv Biomed | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.26B | 25x | -1.15 | NT$61.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kim Forest Enterprise | Taiwan | Healthcare | Biotechnology & Medical Research | NT$1.18B | -6.7x | 3.34 | NT$19.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inalways | TPEX | Healthcare | Biotechnology & Medical Research | NT$1.01B | 96.8x | 0.44 | NT$20.40 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Taiwan Advance Bio-Pharma | TPEX | Healthcare | Biotechnology & Medical Research | NT$990M | 43.3x | 0.14 | NT$11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SynCore BioTech | TPEX | Healthcare | Biotechnology & Medical Research | NT$952.96M | -18x | 0.07 | NT$27.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLASCO Taiwan | TPEX | Healthcare | Biotechnology & Medical Research | NT$834.95M | 17x | 1 | NT$32.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofiva Genomics | TPEX | Healthcare | Biotechnology & Medical Research | NT$679.11M | -93.2x | 0.73 | NT$31.45 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TaiwanJ Pharmas | TPEX | Healthcare | Biotechnology & Medical Research | NT$603.32M | -23.5x | -1.73 | NT$7.53 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Welgene Biotech | TPEX | Healthcare | Biotechnology & Medical Research | NT$467.25M | 202.3x | 1.65 | NT$20.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |